Patent · US Active

CD20 binding single domain antibodies

US11248057B2 · kind B2 · utility

2Cited by

4References

7Claims

0Family size

Assignees

VIB VZW · BE
UNIVERSITEIT GENT · BE

Inventors

Jan Tavernier · Balegem, BE
Anje CAUWELS · Merelbeke, BE
Jose van der Heyden · Munte, BE

Key dates

Filing date	Mar 7, 2017
Grant date	Feb 15, 2022
Priority date	—
Expiry date	Nov 15, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates, in part, to agents that bind CD20 and their use as therapeutic agents. The present application further relates to pharmaceutical compositions comprising the CD20 binding agents and their use in the treatment of various diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.